ENDRA Corp (NDRA) - Long-Term Debt to Capital Coefficient
The business of ENDRA Life Sciences (NDRA) relies on a single product for analyzing liver fat pathologies, which creates risks in the event of delayed insurance payments. This daily price chart on GURU.Markets, where the metric is 0.05, helps track these processes. ENDRA Life Sciences (NDRA) possesses strong pricing power due to the Thermo Acoustic method, while a strategic alliance with GE Healthcare accelerates the implementation of innovative diagnostics in clinics.
%20Long-Term%20Debt%20to%20Capital&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_NDRA_-_ENDRA-Life-Sciences_-_Long-Term-Debt-to-Capital "NDRA: ENDRA Life Sciences Inc. Long-Term Debt to Capital 07/04/2022 - 10/31/2026 | 👁️GURU.Markets👁️")
Comprehensive metric breakdowns and analytics for ENDRA Life Sciences (NDRA)
The metric is calculated as the ratio of liabilities with a maturity of over one year to total equity. It determines the extent to which financial stability depends on borrowed funds over the long term. For ENDRA Life Sciences (NDRA), this balance is critical when scaling the distribution network and certifying the TAEUS system. An analysis of the long-term debt-to-equity ratio reveals over-leverage risks. This chart's dynamics signal the company's ability to finance expansion without the threat of bankruptcy.